Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
06 Novembro 2008 - 7:38PM
PR Newswire (US)
MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory
Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that Michael
Smith, Chief Financial Officer and Head of Business Development,
will provide a company update at the Rodman & Renshaw Annual
Global Investment Conference on Tuesday, November 11, 2008 at 11:10
a.m. EST at the New York Palace Hotel, in New York City. Interested
parties may access the live webcast of the presentation by visiting
the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com/. Archived versions of the webcast will
be available at the same location for one week following the
presentation. About the Company Memory Pharmaceuticals Corp., a
biopharmaceutical company, is focused on developing innovative
drugs for the treatment of debilitating CNS disorders, many of
which exhibit significant impairment of memory and other cognitive
functions, including Alzheimer's disease and schizophrenia. For
additional information, please visit our website at
http://www.memorypharma.com/. DATASOURCE: Memory Pharmaceuticals
Corp. CONTACT: Jzaneen Lalani, General Counsel of Memory
Pharmaceuticals Corp., +1-201-802-7249; or Laura Perry of LMP
Investor Relations Inc., +1-646-719-1055, of Memory Pharmaceuticals
Corp. Web Site: http://www.memorypharma.com/
Copyright
Memory Pharmaceuticals Corp (MM) (NASDAQ:MEMY)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Memory Pharmaceuticals Corp (MM) (NASDAQ:MEMY)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Memory Pharmaceuticals Corp (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Memory Pharmaceuticals (MM)